Tag Archives: Oncotype DX

BS stands for Blue Shield

Dr. Esserman ordered the Oncotype DX Test for me over 1 month ago (see post “What is Oncotype DX?”) Today I received Blue Shield’s denial letter stating: “A physician advisor has reviewed the information provided and determined that the requested service … Continue reading

Posted in Options, Personal Stories, Resources | Tagged , , , | 4 Comments

What Is Oncotype DX?

Oncotype DX is the first clinically validated commercial genomic assay for patients with DCIS. Oncotype DX reveals the underlying biology that can help guide DCIS treatment decisions by predicting the risk of any local recurrence of breast cancer (DCIS or … Continue reading

Posted in Options, Resources | Tagged , | Leave a comment